- Home
- PCTY vs QGEN Comparison
PCTY vs QGEN Comparison
Compare PCTY & QGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCTY
- QGEN
- Stock Information
- Founded
- PCTY 1997
- QGEN 1986
- Country
- PCTY United States
- QGEN Netherlands
- Employees
- PCTY N/A
- QGEN N/A
- Industry
- PCTY Computer Software: Prepackaged Software
- QGEN Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PCTY Technology
- QGEN Health Care
- Exchange
- PCTY Nasdaq
- QGEN Nasdaq
- Market Cap
- PCTY 9.9B
- QGEN 10.1B
- IPO Year
- PCTY 2014
- QGEN 1996
- Fundamental
- Price
- PCTY $154.75
- QGEN $47.79
- Analyst Decision
- PCTY Buy
- QGEN Buy
- Analyst Count
- PCTY 18
- QGEN 8
- Target Price
- PCTY $221.06
- QGEN $51.01
- AVG Volume (30 Days)
- PCTY 592.2K
- QGEN 1.1M
- Earning Date
- PCTY 10-29-2025
- QGEN 11-05-2025
- Dividend Yield
- PCTY N/A
- QGEN 3.23%
- EPS Growth
- PCTY 10.74
- QGEN 405.09
- EPS
- PCTY 4.02
- QGEN 1.69
- Revenue
- PCTY $1,595,221,000.00
- QGEN $2,040,067,000.00
- Revenue This Year
- PCTY $9.77
- QGEN $7.37
- Revenue Next Year
- PCTY $8.97
- QGEN $5.70
- P/E Ratio
- PCTY $38.38
- QGEN $27.64
- Revenue Growth
- PCTY 13.74
- QGEN 5.15
- 52 Week Low
- PCTY $151.71
- QGEN $37.63
- 52 Week High
- PCTY $223.80
- QGEN $51.88
- Technical
- Relative Strength Index (RSI)
- PCTY 28.01
- QGEN 56.92
- Support Level
- PCTY $151.96
- QGEN $43.74
- Resistance Level
- PCTY $157.45
- QGEN $47.16
- Average True Range (ATR)
- PCTY 3.85
- QGEN 0.62
- MACD
- PCTY -0.65
- QGEN 0.36
- Stochastic Oscillator
- PCTY 5.08
- QGEN 96.49
About PCTY Paylocity Holding Corporation
Founded in 1997, Paylocity is a cloud-based human capital management and payroll platform servicing midmarket customers. The company's average client size is around 150 employees. Its products help with recruiting and onboarding, payroll, time and labor, human resources, benefits, learning, and performance and compensation workflows. In fiscal 2025, the company generated over $1.5 billion in revenue across more than 41,000 customers.
About QGEN Qiagen N.V.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2024 sales), followed by EMEA (33%), and the Asia-Pacific (15%).